# Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease

> **NCT01328470** · PHASE4 · COMPLETED · sponsor: **Kyunghee University Medical Center** · enrollment: 85 (actual)

## Conditions studied

- Chronic Kidney Disease
- Stable Angina

## Interventions

- **DRUG:** Clopidogrel, cilostazol

## Key facts

- **NCT ID:** NCT01328470
- **Lead sponsor:** Kyunghee University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2011-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328470, "Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01328470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*